# Reliance Global Group, Inc.: financial statements, quarterly

EZRA · Nasdaq · CIK 1812727 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ezra.md) · [Financials](/companies/ezra/financials.md) · [Filings](/companies/ezra/filings.md) · [Insiders](/companies/ezra/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ezra/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,276](/filings/0001493152-24-044014.md) | [3,321 d](/filings/0001493152-25-009445.md) | [4,082](/filings/0001641172-25-010313.md) | [3,233](/filings/0001641172-25-021555.md) | [3,441](/filings/0001493152-24-044014.md) | [3,297 d](/filings/0001493152-26-009536.md) | [4,236](/filings/0001641172-25-010313.md) | [3,087](/filings/0001641172-25-021555.md) | [2,496](/filings/0001493152-25-021089.md) | [2,612 d](/filings/0001493152-26-009536.md) | [3,827](/filings/0001493152-26-021761.md) | [2,111](/filings/0001493152-26-035504.md) |
| Operating income | $k | [(1,435)](/filings/0001493152-24-044014.md) | [(9,601) d](/filings/0001493152-25-009445.md) | [(5,032)](/filings/0001641172-25-010313.md) | [(1,147)](/filings/0001641172-25-021555.md) | [(512)](/filings/0001493152-25-021089.md) | [(1,005) d](/filings/0001493152-26-009536.md) | [(1,407)](/filings/0001493152-26-021761.md) | [(2,372)](/filings/0001493152-26-035504.md) | [(3,914)](/filings/0001493152-25-021089.md) | [(1,320) d](/filings/0001493152-26-009536.md) | [(1,240)](/filings/0001493152-26-021761.md) | [(1,824)](/filings/0001493152-26-035504.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0](/filings/0001493152-24-044014.md) | not reported | [0.0](/filings/0001641172-25-010313.md) | [0.0](/filings/0001493152-24-029072.md) | [0.0](/filings/0001493152-25-021089.md) | not reported | [0.0](/filings/0001493152-26-021761.md) | [0.0](/filings/0001493152-26-035504.md) | [0.0](/filings/0001493152-25-021089.md) | not reported | [0.0](/filings/0001493152-26-021761.md) | [0.0](/filings/0001493152-26-035504.md) |
| Net income | $k | [(139)](/filings/0001493152-24-044014.md) | [(9,027) d](/filings/0001493152-25-009445.md) | [(5,347)](/filings/0001493152-25-021089.md) | [(1,489)](/filings/0001493152-25-021089.md) | [(837)](/filings/0001493152-25-021089.md) | [(1,398) d](/filings/0001493152-26-009536.md) | [(1,737)](/filings/0001493152-26-021761.md) | [(2,711)](/filings/0001493152-26-035504.md) | [(1,157)](/filings/0001493152-25-021089.md) | [(1,383) d](/filings/0001493152-26-009536.md) | [(1,471)](/filings/0001493152-26-021761.md) | [(1,991)](/filings/0001493152-26-035504.md) |
| Diluted EPS | $ per share | [(0.78)](/filings/0001493152-24-044014.md) | not reported | [(13.84)](/filings/0001641172-25-010313.md) | [(2.76)](/filings/0001641172-25-021555.md) | [(0.67)](/filings/0001493152-25-021089.md) | not reported | [(0.66)](/filings/0001493152-26-021761.md) | [(33.90)](/filings/0001493152-26-035504.md) | [(0.20)](/filings/0001493152-25-021089.md) | not reported | [(0.09)](/filings/0001493152-26-021761.md) | [(3.26)](/filings/0001493152-26-035504.md) |
| Basic EPS | $ per share | [(0.78)](/filings/0001493152-24-044014.md) | not reported | [(13.84)](/filings/0001641172-25-010313.md) | [(2.76)](/filings/0001641172-25-021555.md) | [(0.67)](/filings/0001493152-25-021089.md) | not reported | [(0.66)](/filings/0001493152-26-021761.md) | [(33.90)](/filings/0001493152-26-035504.md) | [(0.20)](/filings/0001493152-25-021089.md) | not reported | [(0.09)](/filings/0001493152-26-021761.md) | [(3.26)](/filings/0001493152-26-035504.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.8](/filings/0001493152-24-044014.md) | [1.3](/filings/0001493152-25-009445.md) | [0.7](/filings/0001641172-25-010313.md) | [1.4](/filings/0001641172-25-021555.md) | [0.9](/filings/0001493152-25-021089.md) | [0.4](/filings/0001493152-26-009536.md) | [0.4](/filings/0001493152-26-021761.md) | [2.0](/filings/0001493152-26-035504.md) | [2.6](/filings/0001493152-25-021089.md) | [1.3](/filings/0001493152-26-035504.md) | [2.3](/filings/0001493152-26-021761.md) | [0.8](/filings/0001493152-26-035504.md) |
| Current assets | $m | [4.7](/filings/0001493152-23-040510.md) | [4.4](/filings/0001493152-25-009445.md) | [3.4](/filings/0001493152-24-020681.md) | [4.3](/filings/0001493152-24-029072.md) | [3.8](/filings/0001493152-24-044014.md) | [4.0](/filings/0001493152-26-009536.md) | [3.9](/filings/0001641172-25-010313.md) | [7.1](/filings/0001641172-25-021555.md) | [5.0](/filings/0001493152-25-021089.md) | [4.3](/filings/0001493152-26-035504.md) | [4.5](/filings/0001493152-26-021761.md) | [3.2](/filings/0001493152-26-035504.md) |
| Total assets | $m | [31.7](/filings/0001493152-23-040510.md) | [23.0](/filings/0001493152-25-009445.md) | [17.5](/filings/0001493152-24-020681.md) | [18.3](/filings/0001493152-24-029072.md) | [17.4](/filings/0001493152-24-044014.md) | [17.3](/filings/0001493152-26-009536.md) | [16.8](/filings/0001641172-25-010313.md) | [18.0](/filings/0001641172-25-021555.md) | [15.7](/filings/0001493152-25-021089.md) | [13.5](/filings/0001493152-26-035504.md) | [13.8](/filings/0001493152-26-021761.md) | [12.9](/filings/0001493152-26-035504.md) |
| Current liabilities | $m | [3.9](/filings/0001493152-23-040510.md) | [3.2](/filings/0001493152-25-009445.md) | [3.5](/filings/0001493152-24-020681.md) | [3.7](/filings/0001493152-24-029072.md) | [3.4](/filings/0001493152-24-044014.md) | [3.6](/filings/0001493152-26-009536.md) | [3.9](/filings/0001641172-25-010313.md) | [5.0](/filings/0001641172-25-021555.md) | [3.4](/filings/0001493152-25-021089.md) | [2.4](/filings/0001493152-26-035504.md) | [1.9](/filings/0001493152-26-021761.md) | [1.9](/filings/0001493152-26-035504.md) |
| Total liabilities | $m | [17.8](/filings/0001493152-23-040510.md) | [15.9](/filings/0001493152-25-009445.md) | [15.6](/filings/0001493152-24-020681.md) | [15.5](/filings/0001493152-24-029072.md) | [14.6](/filings/0001493152-24-044014.md) | [14.3](/filings/0001493152-26-009536.md) | [14.2](/filings/0001641172-25-010313.md) | [14.9](/filings/0001641172-25-021555.md) | [8.9](/filings/0001493152-25-021089.md) | [7.1](/filings/0001493152-26-035504.md) | [6.4](/filings/0001493152-26-021761.md) | [6.2](/filings/0001493152-26-035504.md) |
| Long-term debt | $m | [11.4](/filings/0001493152-23-040510.md) | [11.0](/filings/0001493152-25-009445.md) | [10.7](/filings/0001493152-24-020681.md) | [10.3](/filings/0001493152-24-029072.md) | [9.9](/filings/0001493152-24-044014.md) | [9.5](/filings/0001493152-26-009536.md) | [9.1](/filings/0001641172-25-010313.md) | [8.6](/filings/0001641172-25-021555.md) | [4.6](/filings/0001493152-25-021089.md) | [4.1](/filings/0001493152-26-035504.md) | [3.9](/filings/0001493152-26-021761.md) | [3.8](/filings/0001493152-26-035504.md) |
| Current portion of debt | $m | [1.4](/filings/0001493152-23-040510.md) | [1.4](/filings/0001493152-25-009445.md) | [1.4](/filings/0001493152-24-020681.md) | [1.5](/filings/0001493152-24-029072.md) | [1.5](/filings/0001493152-24-044014.md) | [1.6](/filings/0001493152-26-009536.md) | [1.6](/filings/0001641172-25-010313.md) | [1.7](/filings/0001641172-25-021555.md) | [0.6](/filings/0001493152-25-021089.md) | [1.0](/filings/0001493152-26-035504.md) | [0.6](/filings/0001493152-26-021761.md) | [0.6](/filings/0001493152-26-035504.md) |
| Short-term borrowings | $m | not reported | [0.1](/filings/0001493152-25-009445.md) | [0.0](/filings/0001493152-24-020681.md) | [0.1](/filings/0001493152-24-029072.md) | [0.1](/filings/0001493152-24-044014.md) | [0.1](/filings/0001493152-26-009536.md) | [0.0](/filings/0001641172-25-010313.md) | [0.1](/filings/0001641172-25-021555.md) | [0.1](/filings/0001493152-25-021089.md) | [0.1](/filings/0001493152-26-035504.md) | [0.0](/filings/0001493152-26-021761.md) | [0.1](/filings/0001493152-26-035504.md) |
| Shareholders' equity | $m | [13.9](/filings/0001493152-24-044014.md) | [7.1](/filings/0001493152-26-009536.md) | [2.0](/filings/0001493152-25-021089.md) | [2.9](/filings/0001493152-25-021089.md) | [2.8](/filings/0001493152-25-021089.md) | [3.0](/filings/0001493152-26-021761.md) | [2.6](/filings/0001493152-26-021761.md) | [3.1](/filings/0001493152-25-021089.md) | [6.7](/filings/0001493152-25-021089.md) | [6.4](/filings/0001493152-26-035504.md) | [7.4](/filings/0001493152-26-021761.md) | [6.7](/filings/0001493152-26-035504.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,990 d](/filings/0001493152-24-044014.md) | [(831) d](/filings/0001493152-25-009445.md) | [(204)](/filings/0001641172-25-010313.md) | [(685) d](/filings/0001641172-25-021555.md) | [(758) d](/filings/0001493152-25-021089.md) | [(867) d](/filings/0001493152-26-009536.md) | [198](/filings/0001493152-26-021761.md) | [(853) d](/filings/0001493152-26-035504.md) | [(814) d](/filings/0001493152-25-021089.md) | [(1,625) d](/filings/0001493152-26-009536.md) | [(571)](/filings/0001493152-26-021761.md) | [(1,660) d](/filings/0001493152-26-035504.md) |
| Capital expenditure | $k | [8.2 d](/filings/0001493152-24-044014.md) | [1.7 d](/filings/0001493152-25-009445.md) | [12.3](/filings/0001641172-25-010313.md) | [3.1 d](/filings/0001641172-25-021555.md) | [3.6 d](/filings/0001493152-25-021089.md) | [5.2 d](/filings/0001493152-26-009536.md) | [5.3](/filings/0001493152-26-021761.md) | [4.2 d](/filings/0001493152-26-035504.md) | [6.4 d](/filings/0001493152-25-021089.md) | [0.0 d](/filings/0001493152-26-009536.md) | not reported | not reported |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [131](/filings/0001493152-26-021761.md) | [0.0 d](/filings/0001493152-26-035504.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.3](/filings/0001493152-23-040510.md) | [2.2](/filings/0001493152-24-020681.md) | [0.2](/filings/0001493152-24-029072.md) | [0.2](/filings/0001493152-24-044014.md) | [0.4](/filings/0001641172-25-010313.md) | [0.5](/filings/0001641172-25-021555.md) | [1.3](/filings/0001493152-25-021089.md) | [2.6](/filings/0001493152-26-021761.md) | [0.1](/filings/0001493152-26-035504.md) | [5.8](/filings/0001493152-25-021089.md) | [17.0](/filings/0001493152-26-021761.md) | [0.6](/filings/0001493152-26-035504.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,002,998 at 2026-07-30, from the cover of the [10-Q filed 2026-07-30](/filings/0001493152-26-035504.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.